See what's new in this month's Newsletter
- Peruse Cencora’s Healthcare Landscape Outlook: Anticipating the top market access trends globally for 2025
- Listen to a recent podcast with the National Association of Specialty Pharmacy on the changing landscape of digital communications for biopharma companies and healthcare decision-makers (HCDMs)
- Explore new and enhanced platform features
- Check out our new FormularyDecisions Insider newsletter archive
Report:
Anticipating the top market access trends globally for 2025
The 2025 healthcare landscape is poised for significant change. Cencora’s report, “Anticipating the top market access trends globally for 2025,” highlights key trends that will impact patient access to innovative therapies.
Key insights include navigating global policy changes, understanding the evolving dynamics between manufacturers and payers, addressing drug pricing pressures, leveraging digital communication for stakeholder engagement, and enhancing equity in US healthcare.
Key insights include navigating global policy changes, understanding the evolving dynamics between manufacturers and payers, addressing drug pricing pressures, leveraging digital communication for stakeholder engagement, and enhancing equity in US healthcare.
Listen on the go – a focus on specialty pharmacy
In this episode of the National Association of Specialty Pharmacy Podcast, explore the changing landscape of digital communication between biopharma companies and healthcare decision-makers (HCDMs) and delve into 3 key topics that are crucial for effective engagement in the digital era with key decision-makers:
- Research on how HCDMs are utilizing digital resources and valuable insights into their preferences
- How biopharma companies are adapting to meet the evolving needs of HCDMs in a post-pandemic peak era
- Innovative strategies to optimize digital communications and the implications for stakeholder relationships
Platform enhancements
2024 enhancements
These features aimed to improve the experience of biopharma companies and HCDMs
- Optimized HCDM content: Targeted email announcements and optimized key pages to better connect HCDMs with subscriber content
- Enhanced eRequest form and insights: Upgraded eRequest capabilities for clearer, more specific requests, enabling biopharma companies to respond more accurately and gain better insights into HCDMs' disease states of interest
- New Cell & Gene Therapy Hub: Exclusive resources to help HCDMs navigate the Cell & Gene Therapy Hub landscape and increase HCDM engagement across the platform
- Updated Biosimilar Hub: New interactive Dashboard and improved landscape overview
- A finalist for the 2024 Pharmaceutical Market Excellence Awards (PMEA) in the category of Excellence in Engagement through Digital Channels and New Technology
Upcoming enhancements
Here are some features we’re working on in 2025
- Payer Landscape Express Surveys: Allows immediate access to HCDM insights via rapidly fielded custom survey questions
- Unapproved Product Dossiers: Enables proactive information sharing with HCDMs to facilitate early engagement and information exchange
- Zoom for AMCP PIE Webinars: Leverages the latest webinar technology and features to enhance communication and interaction
- HCDM Follow Button: Helps HCDMs monitor products of interest and receive notifications when new content becomes available, ensuring they stay informed of the latest updates
- Product Page and Resource Center: Enhances layout, user experience, and organization of content within these pages, making it easier for users to find and access relevant information
- Reimagined Payer Landscape Module: Improves the actionability of survey questions and visuals within the Insights Dashboard, providing more useful insights for biopharma companies
Need assistance with your FormularyDecisions account?
Have a question about your subscription?
Your Subscription Engagement Team is here to assist with an array of activities—from setting up your subscription to digitizing your eDossier, providing technical support, and helping address any other questions that may arise. The FormularyDecisions Subscription Engagement Team is your personalized support backed by a broad, cross-functional team and a suite of self-service tools.
FormularyDecisions is owned and operated by Xcenda L.L.C., which is a subsidiary of Cencora, a global pharmaceutical sourcing and distribution services company.
With regard to the webinars and sessions referenced in this newsletter, FormularyDecisions strongly encourages participants to review all available information related to the topics discussed during such webinars and sessions, and to rely on their experience and expertise in making decisions related thereto.